BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23109156)

  • 1. Dabigatran and thrombolysis: A therapeutic dilemma.
    Govindarajan R; Salgado E
    Ann Neurol; 2012 Oct; 72(4):625; author reply 625-6. PubMed ID: 23109156
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
    De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
    Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
    Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Testai FD
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):894. PubMed ID: 22868184
    [No Abstract]   [Full Text] [Related]  

  • 6. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC; Marrone AC
    Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
    [No Abstract]   [Full Text] [Related]  

  • 8. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Lee VH; Conners JJ; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to the letter by Lee et al.
    Lee V; Conners JJ; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):894. PubMed ID: 22902145
    [No Abstract]   [Full Text] [Related]  

  • 11. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
    Pollack CV; Levy JH; Eikelboom J; Weitz JI; Sellke FW; Huisman MV; Steiner T; Kamphuisen P; Bernstein RA
    Am J Emerg Med; 2014 Nov; 32(11):1433-4. PubMed ID: 25239691
    [No Abstract]   [Full Text] [Related]  

  • 12. Ischemic stroke in patients on dabigatran: a role for rescue thrombectomy?
    Müller P; Windpessl M
    Intern Med; 2015; 54(8):1001. PubMed ID: 25876595
    [No Abstract]   [Full Text] [Related]  

  • 13. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
    Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial thrombolysis in patients treated with warfarin.
    Linfante I; Reddy AS; Andreone V; Caplan LR; Selim M; Hirsch JA
    Cerebrovasc Dis; 2005; 19(2):133-5. PubMed ID: 15637435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Waran following thrombolysis with Actilyse].
    Ohlsson S; Böttiger Y
    Lakartidningen; 2006 Mar 15-21; 103(11):853. PubMed ID: 16613115
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
    Dempfle CE; Hennerici MG
    Cerebrovasc Dis; 2011; 32(6):616-9. PubMed ID: 22133643
    [No Abstract]   [Full Text] [Related]  

  • 17. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
    Sangha N; El Khoury R; Misra V; Lopez G
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Room for improvement in stroke treatment.
    Health News; 2000 May; 6(5):5. PubMed ID: 10851967
    [No Abstract]   [Full Text] [Related]  

  • 20. Redemption by RE-DEEM?
    Moser M; Bode C
    Eur Heart J; 2011 Nov; 32(22):2734-5. PubMed ID: 21565850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.